Medicare Enrolled
Dr. Fariborz Delbakhsh, M.D.
Optician · Summerfield, FL
Practice pattern: Mixed Practice— Diverse clinical practice across multiple procedure types
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Delbakhsh from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Delbakhsh? Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Delbakhsh
Dr. Fariborz Delbakhsh is an optician in Summerfield, FL, with 19 years in practice. Based on federal Medicare data, Dr. Delbakhsh performed 127,569 Medicare services across 59,128 unique beneficiaries.
Between the years covered by Open Payments, Dr. Delbakhsh received a total of $4,795 from 33 pharmaceutical and/or device companies across 189 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in optician. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Delbakhsh is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice▲ Top 1% volume in FL$ $4,795 industry payments
Medicare Practice Summary
Medicare Utilization ↗127,569
Medicare services
Top 1% in FL for optician
59,128
Unique beneficiaries
$18
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~6,714 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Apolipoprotein level | 5,833 | $21 | $42 |
| Measure of severe acute respiratory syndrome coronavirus 2 (covid-19) antibody | 3,648 | $41 | $101 |
| Blood draw (venipuncture) | 3,178 | $7 | $11 |
| Lactate dehydrogenase (enzyme) level | 3,047 | $6 | $13 |
| Creatine kinase (cardiac enzyme) level, total | 3,036 | $6 | $14 |
| Uric acid level test | 3,027 | $4 | $10 |
| Glutamyltransferase (liver enzyme) level | 3,004 | $7 | $16 |
| Calcium level, total | 2,994 | $5 | $11 |
| Complete blood count (CBC) with differential | 2,993 | $8 | $17 |
| Blood creatinine level | 2,988 | $5 | $11 |
| Blood sodium level | 2,985 | $5 | $11 |
| Blood chloride level | 2,983 | $5 | $10 |
| Blood potassium level | 2,981 | $5 | $10 |
| Phosphatase (enzyme) level, alkaline | 2,959 | $5 | $11 |
| Liver enzyme (sgpt), level | 2,957 | $5 | $12 |
| Liver enzyme (sgot), level | 2,956 | $5 | $11 |
| Blood glucose (sugar) level | 2,955 | $4 | $9 |
| Albumin (protein) level | 2,950 | $5 | $11 |
| Bilirubin level, total | 2,949 | $5 | $11 |
| Urea nitrogen level to assess kidney function, quantitative | 2,938 | $4 | $9 |
| Total protein level, blood | 2,935 | $4 | $8 |
| C-reactive protein test (inflammation marker) | 2,911 | $5 | $11 |
| Lipid panel (cholesterol and triglycerides) | 2,906 | $13 | $30 |
| Lipoprotein (a) level | 2,895 | $14 | $29 |
| Vitamin B-12 level test | 2,884 | $15 | $33 |
| Folic acid level test | 2,879 | $14 | $32 |
| Thyroid stimulating hormone (TSH) test | 2,843 | $16 | $37 |
| Free thyroxine (T4) test | 2,836 | $9 | $20 |
| Thyroid hormone, t3 measurement, free | 2,695 | $17 | $37 |
| Thyroglobulin (thyroid protein) antibody measurement | 2,688 | $16 | $35 |
| Microsomal antibodies (autoantibody) measurement | 2,687 | $14 | $32 |
| Urine microalbumin test (kidney screening) | 2,653 | $6 | $13 |
| Creatinine test (kidney function) | 2,647 | $5 | $11 |
| Office visit, established patient (30-39 min) | 2,010 | $92 | $295 |
| Office visit, established patient (20-29 min) | 1,906 | $64 | $201 |
| Hemoglobin A1c test (diabetes monitoring) | 1,753 | $10 | $21 |
| Insulin measurement, total | 1,661 | $11 | $25 |
| C-peptide (protein) level | 1,654 | $20 | $46 |
| Ferritin level test (iron stores) | 1,384 | $13 | $30 |
| Transferrin (iron binding protein) level | 1,382 | $12 | $28 |
| Iron level test | 1,380 | $6 | $14 |
| Chronic care management, first 20 min/month | 1,286 | $34 | $45 |
| Natriuretic peptide (heart and blood vessel protein) level | 1,266 | $38 | $79 |
| Magnesium level test | 1,117 | $7 | $15 |
| Phosphate level test | 1,068 | $5 | $10 |
| Advance care planning consultation, first 30 min | 843 | $80 | $100 |
| Annual alcohol misuse screening, 5 to 15 minutes | 796 | $18 | $50 |
| Annual wellness visit, follow-up | 789 | $126 | $305 |
| Annual depression screening | 787 | $18 | $50 |
| Parathyroid hormone level test | 646 | $40 | $90 |
| Vitamin D level test | 625 | $29 | $65 |
| Chronic care management, additional 20 min/month | 417 | $33 | $45 |
| Complex chronic care management services for two or more chronic conditions, first 60 minutes of clinical staff time directed by health care professional, per calendar month | 387 | $72 | $94 |
| Influenza vaccine, quadrivalent derived from cell cultures | 287 | $32 | $50 |
| Assessment of emotional or behavioral problems | 287 | $3 | $14 |
| Flu vaccine administration | 287 | $30 | $62 |
| Management using the results of remote vital sign monitoring per calendar month, each additional 20 minutes | 235 | $30 | $50 |
| Steroid injection (triamcinolone) | 231 | $1 | $5 |
| Drug injection, under skin or into muscle | 205 | $10 | $70 |
| PSA test (prostate cancer screening) | 189 | $18 | $41 |
| Injection of chemical agent into single incompetent vein of leg using ultrasound guidance | 163 | $993 | $3,875 |
| Complex chronic care management services for two or more chronic conditions, each additional 60 minutes of clinical staff time directed by health care professional, per calendar month | 161 | $36 | $47 |
| Remote patient monitoring management, 20 min/month | 158 | $37 | $65 |
| Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | 147 | $1 | $5 |
| Ultrasound study of arm or leg veins with compression and maneuvers | 144 | $130 | $522 |
| Gonadotropin, follicle stimulating (reproductive hormone) level | 140 | $18 | $41 |
| Gonadotropin, luteinizing (reproductive hormone) level | 138 | $18 | $41 |
| Echocardiogram, transthoracic | 125 | $89 | $512 |
| Chemical destruction of first incompetent vein of arm or leg using imaging guidance | 124 | $1,269 | $5,179 |
| Automated urinalysis | 110 | $2 | $5 |
| Electrocardiogram (EKG), 12-lead | 106 | $10 | $51 |
| Transitional care management services for problem of high complexity | 99 | $214 | $636 |
| Ultrasound study of one arm or leg veins with compression and maneuvers | 77 | $91 | $316 |
| Remote patient monitoring device, 30 days | 74 | $36 | $70 |
| Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | 68 | $39 | $146 |
| Testosterone (hormone) level, total | 64 | $25 | $57 |
| Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus | 56 | $35 | $89 |
| Prolactin (milk producing hormone) level | 55 | $19 | $43 |
| Measurement of total estradiol (hormone) | 54 | $27 | $61 |
| Ultrasound of both sides of head and neck blood flow | 54 | $115 | $655 |
| Comprehensive metabolic blood panel | 53 | $10 | $23 |
| Sex hormone binding globulin (protein) level | 53 | $21 | $48 |
| Cortisol (hormone) measurement, total | 52 | $16 | $36 |
| Testosterone (hormone) level, free | 50 | $25 | $56 |
| Injection, ketorolac tromethamine, per 15 mg | 50 | $0 | $2 |
| Joint injection, major joint | 45 | $49 | $171 |
| Drug screening test | 45 | $61 | $129 |
| Office visit, established patient, complex (40-54 min) | 36 | $136 | $395 |
| Urinalysis, manual | 33 | $3 | $11 |
| Transitional care management services for problem of at least moderate complexity | 31 | $153 | $451 |
| Amplifed dna or rna probe detection of severe acute respiratory syndrome coronavirus 2 (covid-19) antigen | 30 | $50 | $103 |
| Office visit, established patient (10-19 min) | 25 | $42 | $121 |
| Prostate cancer screening; prostate specific antigen test (psa) | 20 | $19 | $40 |
| Infectious disease DNA/RNA test | 19 | $34 | $70 |
| Detection test by nucleic acid for multiple types influenza virus | 18 | $94 | $192 |
| Destruction of first incompetent vein of arm or leg using radiofrequency and imaging guidance | 17 | $834 | $4,923 |
| Kidney function blood test panel | 17 | $9 | $19 |
| Detection test by nucleic acid for chlamydia pneumoniae, amplified probe technique | 16 | $34 | $70 |
| Detection test by nucleic acid for mycoplasma pneumoniae (bacteria), amplified probe technique | 16 | $34 | $70 |
| Detection test by nucleic acid for multiple types of respiratory virus, multiple types or subtypes, 3-5 targets | 16 | $140 | $285 |
| Pneumococcal vaccine, 23-valent | 16 | $117 | $119 |
| Pneumonia vaccine administration | 16 | $30 | $59 |
| Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | 16 | $161 | $450 |
| New patient office visit (45-59 min) | 15 | $116 | $459 |
| Physician or allowed practitioner re-certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians a | 15 | $32 | $114 |
| Basic metabolic blood panel | 12 | $8 | $19 |
| Progesterone (reproductive hormone) level | 11 | $20 | $46 |
| Administration of psychological or neuropsychological test, first 30 minutes | 11 | $33 | $230 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
0.1% high complexity
1.0% medium
98.9% routine
Industry Payment Transparency
Open Payments through 2024 ↗$4,795
Total received (2018-2024)
Avg $685/year across 7 years
Top 24% in FL for optician
33
Companies
189
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$4,659 (97.1%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$137 (2.9%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024$890
2023$966
2022$827
2021$836
2020$362
2019$561
2018$353
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
AstraZeneca Pharmaceuticals LP
$1,226
Amgen Inc.
$366
PFIZER INC.
$273
Novo Nordisk Inc
$258
Avinger Inc.
$244
Lilly USA, LLC
$225
Novartis Pharmaceuticals Corporation
$186
Abbott Laboratories
$171
Sumitomo Pharma America, Inc.
$158
AbbVie Inc.
$157
GlaxoSmithKline, LLC.
$145
Merck Sharp & Dohme Corporation
$142
Astellas Pharma US Inc
$137
GENZYME CORPORATION
$125
Edwards Lifesciences Corporation
$115
Esperion Therapeutics, Inc.
$115
Exact Sciences Corporation
$90
Janssen Pharmaceuticals, Inc
$81
ORGANOGENESIS INC.
$78
Kowa Pharmaceuticals America, Inc.
$70
ABBVIE INC.
$65
Eisai Inc.
$62
Boston Scientific Corporation
$55
BOSTON SCIENTIFIC CORPORATION
$50
Smith+Nephew, Inc.
$38
Organogenesis Inc.
$36
Otsuka America Pharmaceutical, Inc.
$26
Alexion Pharmaceuticals, Inc.
$24
Boehringer Ingelheim Pharmaceuticals, Inc.
$22
Mylan Specialty L.P.
$17
E.R. Squibb & Sons, L.L.C.
$14
AbbVie, Inc.
$13
Arbor Pharmaceuticals, Inc.
$13
Top 3 companies account for 38.9% of total payments
Associated products mentioned in payments ›
AIRSUPRA · ANORO · AREXVY · Aimovig · BREZTRI · CHANTIX · COLLAGENASE SANTYL · COLOGUARD DNA CAPTURE REAGENTS · CREON · Cologuard Collection Kit · Creon · Dayvigo · ELIQUIS · EMGALITY · ENTRESTO · EUCRISA · EVENITY · Edwards SAPIEN 3 Ultra Transcatheter Heart Valve · FABRAZYME · FARXIGA · FREESTYLE LIBRE · FREESTYLE LIBRE 2 · FREESTYLE LIBRE 3 · FreeStyle Libre 2 · GEMTESA · Horizant · JANUVIA · JARDIANCE · LEQVIO · LINZESS · LYRICA · Leqembi · Livalo · MOUNJARO · MYRBETRIQ · NEXLETOL · Otezla · Ozempic · PANTHERIS · PAXLOVID · PREMARIN · Puraply · Puraply Antimicrobial · REXULTI · Repatha · Rybelsus · SHINGRIX · SYNTHROID · Soliris · TOVIAZ · TRELEGY ELLIPTA · TRULICITY · Tresiba · UBRELVY · VARITHENA · VRAYLAR · Varithena Administration Pack · WATCHMAN · WATCHMAN FLX · XARELTO · Yupelri
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (97%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Equivalent to $4 per 100 Medicare services performed
Geographic Context
Opticians within 10 mi
100
Per 100K population
25.8
County median income
$58,535
Nearest hospital
VILLAGES REGIONAL HOSPITAL, THE
10.2 mi
10.2 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Delbakhsh is a mixed practice specialist, with above-average Medicare volume (top 1% in FL), and low-engagement industry engagement, with 19 years of practice experience.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Delbakhsh experienced with apolipoprotein level?
Based on Medicare claims data, Dr. Delbakhsh performed 5,833 apolipoprotein level services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Delbakhsh receive payments from pharmaceutical companies?
Yes. Dr. Delbakhsh received a total of $4,795 from 33 companies across 189 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Delbakhsh's costs compare to other opticians in Summerfield?
Dr. Delbakhsh's average Medicare payment per service is $18. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Delbakhsh) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Opticians in Summerfield
Browse opticians in Summerfield ranked by procedure volume and transparency data.
Highest volume
Top Opticians in FL
Opticians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Opticians in FL
Which FL opticians receive the most from drug and device companies.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
Amgen Inc. Payments to Doctors
See all physicians who received payments from Amgen Inc..
By company
PFIZER INC. Payments to Doctors
See all physicians who received payments from PFIZER INC..
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology